STAGE III UTERINE CORPUS LEIOMYOSARCOMA AJCC V8
Clinical trials for STAGE III UTERINE CORPUS LEIOMYOSARCOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III UTERINE CORPUS LEIOMYOSARCOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III UTERINE CORPUS LEIOMYOSARCOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat uterine cancer: trial tests promising drug duo
Disease control OngoingThis study is for people with advanced uterine leiomyosarcoma, a type of cancer, that has continued to grow despite at least two prior chemotherapy treatments. It compares a new combination of two oral drugs, olaparib and temozolomide, against the current standard chemotherapy op…
Matched conditions: STAGE III UTERINE CORPUS LEIOMYOSARCOMA AJCC V8
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug duo aims to halt aggressive uterine cancer
Disease control OngoingThis study is testing whether combining two drugs, olaparib and temozolomide, can help control advanced uterine leiomyosarcoma, a rare and aggressive cancer. It is for patients whose cancer has spread or cannot be removed by surgery and who have already tried at least one other t…
Matched conditions: STAGE III UTERINE CORPUS LEIOMYOSARCOMA AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug duo tested to halt aggressive sarcoma
Disease control OngoingThis study is testing whether combining two drugs, cabozantinib and temozolomide, can better control advanced soft tissue sarcomas that cannot be removed by surgery or have spread. The trial aims to see if this combination can stop the cancer from growing for longer and improve s…
Matched conditions: STAGE III UTERINE CORPUS LEIOMYOSARCOMA AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC